Dudhe, S.B. and Ghule, S. 2025. Lipid-Based Formulation of Nateglinide as a Promising Strategy for Managing Solubility Challenges in Type II Diabetes Therapy: A SMEDDS Approach. Journal of Neonatal Surgery. 14, 32S (Jun. 2025), 369–377.